#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4350831	F	Antiproliferative activity against patient-derived GBM cells assessed as cell viability after 48 hrs by 5-Ethynyl-2'-deoxyuridine incorporation assay	Homo sapiens	4		cell-based format	Scientific Literature
2.	ALA4350832	F	Potency index, ratio of crizotinib EC50 to compound EC50 for antiproliferative activity against patient-derived GBM cells	Homo sapiens	2		cell-based format	Scientific Literature
3.	ALA4350833	F	Synergistic antiproliferative activity against patient-derived GBM cells assessed as cell viability after 48 hrs in presence of temozolomide by 5-Ethynyl-2'-deoxyuridine incorporation assay	Homo sapiens	3		cell-based format	Scientific Literature
4.	ALA4350834	F	Potency index, ratio of crizotinib EC50 for antiproliferative activity against patient-derived GBM cells to compound EC50 for antiproliferative activity against patient-derived GBM cells in presence of temozolomide	Homo sapiens	2		cell-based format	Scientific Literature
5.	ALA4350835	F	Antiproliferative activity against patient-derived GBM cells assessed as reduction in cell viability after 48 hrs by 5-Ethynyl-2'-deoxyuridine incorporation assay	Homo sapiens	3		cell-based format	Scientific Literature
6.	ALA4350836	F	Potency index, ratio of crizotinib IC50 to compound IC50 for antiproliferative activity against patient-derived GBM cells	Homo sapiens	2		cell-based format	Scientific Literature
7.	ALA4350837	F	Synergistic antiproliferative activity against patient-derived GBM cells assessed as reduction in cell viability after 48 hrs in presence of temozolomide by 5-Ethynyl-2'-deoxyuridine incorporation assay	Homo sapiens	3		cell-based format	Scientific Literature
8.	ALA4350838	F	Potency index, ratio of crizotinib IC50 for antiproliferative activity against patient-derived GBM cells to compound IC50 for antiproliferative activity against patient-derived GBM cells in presence of temozolomide	Homo sapiens	2		cell-based format	Scientific Literature
9.	ALA4350839	A	Substrate activity at OATP in patient-derived GBM cells assessed as compound uptake at 1 uM incubated for 1 hr in presence of OATP inhibitior sodium taurocholic acid by fluorescence microscopic analysis	Homo sapiens	1		cell-based format	Scientific Literature
10.	ALA4350840	A	Substrate activity at OATP in patient-derived GBM cells assessed as compound uptake at 1 uM incubated for 1 hr in presence of OATP activator 3,4-Dihydroxybenzoic acid by fluorescence microscopic analysis	Homo sapiens	1		cell-based format	Scientific Literature
11.	ALA4350841	F	Cytotoxicity against patient-derived GBM cells assessed as LDH release after 96 hrs by spectrophotometric method	Homo sapiens	3		cell-based format	Scientific Literature
12.	ALA4350842	F	Selectivity ratio of EC50 for antiproliferative activity against patient-derived GBM cells to EC50 for antiproliferative activity against patient-derived GBM cells in presence of temozolomide	Homo sapiens	2		cell-based format	Scientific Literature